TriMas Corporation TRS
39.15
(0.32)
(0.81%)
as of 25 Sep
- Market cap
- $1.4B
- P/E
- 1.6×
Follow TRS
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
1.87 | 1.49 | 11.78 | 35.45 |
+8 more quarters Free account |
P/S ratio |
2.10 | 1.76 | 1.88 | 2.98 | |
P/FCF ratio |
0.00 | 27.88 | 20.33 | 35.39 | |
P/Operating CF |
(41.94) | (69.41) | 33.84 | 43.05 | |
P/B ratio |
1.12 | 0.93 | 1.99 | 2.17 | |
Price to Tangible BV |
1.51 | 1.25 | 4.27 | 8.74 | |
EV/Sales |
1.00 | 0.57 | 2.46 | 3.69 | |
EV/EBITDA |
16.41 | 9.03 | 38.87 | 26.37 | |
EV/Operating CF |
38.29 | 4.86 | 15.70 | 18.87 | |
EV/FCF |
(67.61) | 8.96 | 26.69 | 43.81 | |
Quick Ratio |
4.91 | 4.39 | 0.77 | 1.25 | |
Current Ratio |
5.44 | 4.85 | 2.52 | 2.68 | |
Net Debt/EBITDA |
(40.19) | (42.17) | (16.20) | 11.92 | |
Debt/Assets |
17.67% | 17.27% | 31.59% | 28.39% | |
Debt/Equity |
0.28 | 0.27 | 0.66 | 0.56 | |
Asset Turnover |
0.42 | 0.41 | 0.53 | 0.38 | |
Operating CF/Net income |
(2.88) | (0.02) | 0.51 | 3.92 | |
Capex/Depreciation |
(0.78) | (0.35) | (0.32) | (0.93) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
14.03% | 17.82% | 24.54% | 15.28% | |
Intangible Assets out of Total Assets |
0.16 | 0.16 | 0.25 | 0.38 | |
Share Based Compensation of Revenue |
1.34% | 1.82% | 2.08% | 1.23% | |
Graham Net Nets |
0.46 | 0.55 | (0.23) | (0.14) | |
Graham Number |
147.54 | 144.93 | 34.72 | 20.91 | |
Earnings Yield |
53.43% | 67.06% | 8.49% | 2.82% | |
Free Cash Flow Yield |
(0.71%) | 3.59% | 4.92% | 2.83% | |
Revenue per Share |
4.87 | 4.50 | 3.92 | 6.62 | |
Operating CF per Share |
(1.07) | (0.52) | 1.05 | 0.90 | |
Capex per Share |
(0.22) | (0.14) | (0.12) | (0.34) | |
Free Cash Flow per Share |
(1.29) | (0.66) | 0.93 | 0.56 | |
Cash per Share |
34.63 | 34.99 | 0.76 | 0.83 | |
Shareholders Equity per Share |
40.21 | 38.74 | 17.80 | 17.84 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
40.21 | 38.74 | 17.80 | 17.84 | |
Free Cash Flow |
(46.43) | (24.60) | 36.82 | 22.82 | |
Working Capital |
1,262.98 | 1,262.42 | 279.00 | 303.08 | |
Capital Expenditures |
(7.91) | (5.22) | (4.70) | (13.67) | |
Net Current Asset Value |
744.12 | 742.62 | (316.82) | (225.67) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 251.52 | |
Capex to Sales |
0.05 | 0.03 | 0.03 | 0.05 | |
Net Profit Margin |
7.66% | 475.89% | 52.54% | 3.45% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 203.20 | |
| Other line items | |||||
Average Receivables |
178.71 | 156.23 | 113.43 | 177.66 | |
Average Payables |
163.08 | 177.27 | 72.32 | 85.58 | |
Average Inventory |
166.72 | 168.08 | 109.58 | 220.55 | |
Average Assets |
1,845.53 | 1,845.44 | 1,404.63 | 1,400.86 | |
Average Common Equity |
1,078.94 | 1,068.19 | 686.45 | 703.89 |
Columns are period end dates